187 related articles for article (PubMed ID: 34737303)
1. Molecular mechanisms of the CdnG-Cap5 antiphage defense system employing 3',2'-cGAMP as the second messenger.
Fatma S; Chakravarti A; Zeng X; Huang RH
Nat Commun; 2021 Nov; 12(1):6381. PubMed ID: 34737303
[TBL] [Abstract][Full Text] [Related]
2. Activation of CBASS Cap5 endonuclease immune effector by cyclic nucleotides.
Rechkoblit O; Sciaky D; Kreitler DF; Buku A; Kottur J; Aggarwal AK
Nat Struct Mol Biol; 2024 May; 31(5):767-776. PubMed ID: 38321146
[TBL] [Abstract][Full Text] [Related]
3. Phage anti-CBASS and anti-Pycsar nucleases subvert bacterial immunity.
Hobbs SJ; Wein T; Lu A; Morehouse BR; Schnabel J; Leavitt A; Yirmiya E; Sorek R; Kranzusch PJ
Nature; 2022 May; 605(7910):522-526. PubMed ID: 35395152
[TBL] [Abstract][Full Text] [Related]
4. Specific recognition of cyclic oligonucleotides by Cap4 for phage infection.
Chang JJ; You BJ; Tien N; Wang YC; Yang CS; Hou MH; Chen Y
Int J Biol Macromol; 2023 May; 237():123656. PubMed ID: 36796558
[TBL] [Abstract][Full Text] [Related]
5. Bacterial cGAS-like enzymes produce 2',3'-cGAMP to activate an ion channel that restricts phage replication.
Tak U; Walth P; Whiteley AT
bioRxiv; 2023 Jul; ():. PubMed ID: 37546940
[TBL] [Abstract][Full Text] [Related]
6. Cyclic GMP-AMP signalling protects bacteria against viral infection.
Cohen D; Melamed S; Millman A; Shulman G; Oppenheimer-Shaanan Y; Kacen A; Doron S; Amitai G; Sorek R
Nature; 2019 Oct; 574(7780):691-695. PubMed ID: 31533127
[TBL] [Abstract][Full Text] [Related]
7. Structures of c-di-GMP/cGAMP degrading phosphodiesterase VcEAL: identification of a novel conformational switch and its implication.
Yadav M; Pal K; Sen U
Biochem J; 2019 Nov; 476(21):3333-3353. PubMed ID: 31647518
[TBL] [Abstract][Full Text] [Related]
8. CBASS Immunity Uses CARF-Related Effectors to Sense 3'-5'- and 2'-5'-Linked Cyclic Oligonucleotide Signals and Protect Bacteria from Phage Infection.
Lowey B; Whiteley AT; Keszei AFA; Morehouse BR; Mathews IT; Antine SP; Cabrera VJ; Kashin D; Niemann P; Jain M; Schwede F; Mekalanos JJ; Shao S; Lee ASY; Kranzusch PJ
Cell; 2020 Jul; 182(1):38-49.e17. PubMed ID: 32544385
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-like conjugation by bacterial cGAS enhances anti-phage defence.
Jenson JM; Li T; Du F; Ea CK; Chen ZJ
Nature; 2023 Apr; 616(7956):326-331. PubMed ID: 36848932
[TBL] [Abstract][Full Text] [Related]
10. CBASS phage defense and evolution of antiviral nucleotide signaling.
Duncan-Lowey B; Kranzusch PJ
Curr Opin Immunol; 2022 Feb; 74():156-163. PubMed ID: 35123147
[TBL] [Abstract][Full Text] [Related]
11. Effector-mediated membrane disruption controls cell death in CBASS antiphage defense.
Duncan-Lowey B; McNamara-Bordewick NK; Tal N; Sorek R; Kranzusch PJ
Mol Cell; 2021 Dec; 81(24):5039-5051.e5. PubMed ID: 34784509
[TBL] [Abstract][Full Text] [Related]
12. Novel Mechanism for Cyclic Dinucleotide Degradation Revealed by Structural Studies of Vibrio Phosphodiesterase V-cGAP3.
Deng MJ; Tao J; E C; Ye ZY; Jiang Z; Yu J; Su XD
J Mol Biol; 2018 Dec; 430(24):5080-5093. PubMed ID: 30365951
[TBL] [Abstract][Full Text] [Related]
13. Second messengers and divergent HD-GYP phosphodiesterases regulate 3',3'-cGAMP signaling.
Wright TA; Jiang L; Park JJ; Anderson WA; Chen G; Hallberg ZF; Nan B; Hammond MC
Mol Microbiol; 2020 Jan; 113(1):222-236. PubMed ID: 31665539
[TBL] [Abstract][Full Text] [Related]
14. Direct activation of a phospholipase by cyclic GMP-AMP in El Tor
Severin GB; Ramliden MS; Hawver LA; Wang K; Pell ME; Kieninger AK; Khataokar A; O'Hara BJ; Behrmann LV; Neiditch MB; Benning C; Waters CM; Ng WL
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6048-E6055. PubMed ID: 29891656
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the two-component abortive phage infection mechanism AbiT from Lactococcus lactis.
Bouchard JD; Dion E; Bissonnette F; Moineau S
J Bacteriol; 2002 Nov; 184(22):6325-32. PubMed ID: 12399502
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary and functional classification of the CARF domain superfamily, key sensors in prokaryotic antivirus defense.
Makarova KS; Timinskas A; Wolf YI; Gussow AB; Siksnys V; Venclovas Č; Koonin EV
Nucleic Acids Res; 2020 Sep; 48(16):8828-8847. PubMed ID: 32735657
[TBL] [Abstract][Full Text] [Related]
17. Phage anti-CBASS protein simultaneously sequesters cyclic trinucleotides and dinucleotides.
Cao X; Xiao Y; Huiting E; Cao X; Li D; Ren J; Guan L; Wang Y; Li L; Bondy-Denomy J; Feng Y
bioRxiv; 2023 Jun; ():. PubMed ID: 37398474
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights on the recognition of a Lactococcus lactis cell wall pellicle by the phage 1358 receptor binding protein.
Farenc C; Spinelli S; Vinogradov E; Tremblay D; Blangy S; Sadovskaya I; Moineau S; Cambillau C
J Virol; 2014 Jun; 88(12):7005-15. PubMed ID: 24719416
[TBL] [Abstract][Full Text] [Related]
19. A large-scale type I CBASS antiphage screen identifies the phage prohead protease as a key determinant of immune activation and evasion.
Richmond-Buccola D; Hobbs SJ; Garcia JM; Toyoda H; Gao J; Shao S; Lee ASY; Kranzusch PJ
Cell Host Microbe; 2024 Jun; ():. PubMed ID: 38917809
[TBL] [Abstract][Full Text] [Related]
20. Cyclic di-AMP Oversight of Counter-Ion Osmolyte Pools Impacts Intrinsic Cefuroxime Resistance in Lactococcus lactis.
Pham HT; Shi W; Xiang Y; Foo SY; Plan MR; Courtin P; Chapot-Chartier MP; Smid EJ; Liang ZX; Marcellin E; Turner MS
mBio; 2021 Apr; 12(2):. PubMed ID: 33832972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
